Ahmad Kazemi

851 total citations
49 papers, 637 citations indexed

About

Ahmad Kazemi is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ahmad Kazemi has authored 49 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Ahmad Kazemi's work include Acute Lymphoblastic Leukemia research (11 papers), Blood properties and coagulation (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Ahmad Kazemi is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Blood properties and coagulation (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Ahmad Kazemi collaborates with scholars based in Iran, United States and Sweden. Ahmad Kazemi's co-authors include Majid Safa, Farhad Zaker, Fatemeh Alikarami‬, Mohammad H. Derakhshan, Valerie Fyfe, Abbas Yazdanbod, Hirotsugu Watabe, Nasser Rakhshani, Masoud Sotoudeh and Kenneth E.L. McColl and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and FEBS Letters.

In The Last Decade

Ahmad Kazemi

49 papers receiving 624 citations

Peers

Countries citing papers authored by Ahmad Kazemi

Since Specialization

Citations

This map shows the geographic impact of Ahmad Kazemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Kazemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Kazemi more than expected).

Fields of papers citing papers by Ahmad Kazemi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Kazemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Kazemi. The network helps show where Ahmad Kazemi may publish in the future.

Co-authorship network of co-authors of Ahmad Kazemi

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Kazemi. A scholar is included among the top collaborators of Ahmad Kazemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Kazemi. Ahmad Kazemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lower Levels of TET2 Gene Expression, with a Higher Level of TET2 Promoter Methylation in Patients with AML; Evidence for the Role of Aberrant Methylation in AML Pathogenesis 2023 ·Indian Journal of Hematology and Blood Transfusion ·(unknown), (unknown), Farhad Zaker, (unknown), (unknown), Ahmad Kazemi	1
2	Effects of Reduced Mir-24 Expression on Plasma Methotrexate Levels, Therapy-Related Toxicities, and Patient Outcomes in Pediatric Acute Lymphoblastic Leukemia. 2020 ·PubMed Central ·(unknown), Ahmad Kazemi, (unknown), Mohammad Faranoush, (unknown)	5
3	The Prognostic Impact of WT1 Expression Levels, Mutations, and SNP rs16754 in AML Patients: A Retrospective Cohort Study 2020 ·Journal of Advances in Medical and Biomedical Research ·(unknown), Ahmad Kazemi, Bahram Chahardouli, Saeed Mohammadi, Mohsen Nikbakht, (unknown), (unknown), Kamran Alimoghaddam, (unknown)	2
4	Detection of R882 Mutations in DNMT3A Gene in Acute Myeloid Leukemia: A Method Comparison Study 2018 ·(unknown), Bahram Chahardouli, Saeed Mohammadi, Mohsen Nikbakht, (unknown), Farhad Zaker, Shahrbano Rostami, Ahmad Kazemi	1
5	RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways 2018 ·Anti-Cancer Drugs ·(unknown), Maryam Karimi, Fatemeh Alikarami‬, Elham Farhadi, (unknown), Davood Bashash, (unknown), Parviz Kokhaei, (unknown), Ahmad Kazemi, Majid Safa	8
6	CREB knockdown inhibits growth and induces apoptosis in human pre-B acute lymphoblastic leukemia cells through inhibition of prosurvival signals 2017 ·Biomedicine & Pharmacotherapy ·(unknown), Majid Safa, Fatemeh Alikarami‬, Mehdi Banan, Ahmad Kazemi	26
7	Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin 2017 ·Biomedicine & Pharmacotherapy ·Fatemeh Alikarami‬, Majid Safa, Mohammad Faranoush, Parisa Hayat, Ahmad Kazemi	27
8	Molecular characterization of Glanzmann's thrombasthenia in Iran 2017 ·Blood Coagulation & Fibrinolysis ·Ahmad Kazemi, Hassan Abolghasemi, (unknown), Reza Vahidi, Mohammad Faranoush, Alireza Farsinejad, F. Ala	5
9	Laboratory Diagnosis of Congenital Factor V Deficiency, Routine, Specific Coagulation Tests with Molecular Methods 2016 ·SHILAP Revista de lepidopterología ·Shadi Tabibian, Ahmad Kazemi, Akbar Dorgalaleh	1
10	Disseminated intravascular coagulation with positive D-dimer 2016 ·Blood Coagulation & Fibrinolysis ·Majid Naderi, Shadi Tabibian, Marzia Menegatti, Fakher Rahim, Ahmad Kazemi, Farhad Zaker, Akbar Dorgalaleh	5
11	MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway 2015 ·Tumor Biology ·Ahmad Fatemi, Majid Safa, Ahmad Kazemi	28
12	Evaluation Of BIBR1532 And ATRA Combination In NB4 Cell Line 2014 ·SHILAP Revista de lepidopterología ·(unknown), Ahmad Kazemi, (unknown), Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed H. Ghaffari	1
13	Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance 2013 ·Hematology ·Bahram Chahardouli, Farhad Zaker, Seied Asadollah Mousavi, Ahmad Kazemi, (unknown), Fatemeh Nadali, (unknown), Kamran Alimoghaddam, (unknown)	17
14	HIF-1α Confers Resistance to Induced Stress in Bone Marrow-derived Mesenchymal Stem Cells 2013 ·Archives of Medical Research ·Ali Asghar Kiani, Ahmad Kazemi, Raheleh Halabian, (unknown), Ali Jahanian‐Najafabadi, Mehryar Habibi Roudkenar	39
15	Effect Of HESA-A On Acute Promyelocytic Cell Line(NB4) 2012 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Ahmad Kazemi, Hossein Dargahi, (unknown), (unknown), Seyed Nasser Ostad	1
16	Association of platelet collagen receptor polymorphisms with premature acute myocardial infarction 2012 ·Blood Coagulation & Fibrinolysis ·Ahmad Kazemi, Ahmad Fatemi, (unknown), Mohammad Mehdi Peighambari	2
17	Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cellsin vitro 2011 ·Journal of Receptors and Signal Transduction ·Majid Safa, Ahmad Kazemi, (unknown), (unknown)	11
18	Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method 2011 ·Platelets ·Alireza Farsinejad, Hassan Abolghasemi, Ahmad Kazemi, (unknown), (unknown), Mohammad Faranoush, (unknown), F. Ala	9
19	Elevation of cyclic AMP causes an imbalance between NF‐κB and p53 in NALM‐6 cells treated by doxorubicin 2010 ·FEBS Letters ·Majid Safa, Hamid Zand, Kazem Mousavizadeh‬, Ahmad Kazemi, Masoomeh Bakhshayesh, Parisa Hayat	13
20	Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues 2009 ·APOPTOSIS ·Majid Safa, Ahmad Kazemi, Hamid Zand, Azita Azarkeivan, Farhad Zaker, Parisa Hayat	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact